Remove 2017 Remove DEA Remove Patients Remove Treatment
article thumbnail

Nevada veterinarians can now treat patients with certain cannabis products

Cannabis Law Report

Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. 1, 2017, following a 2016 ballot measure. But do medical cannabinoids actually help animal patients? tetrahydrocannabinol without fear of sanction from the state licensing board. A simple question.

Patients 105
article thumbnail

5 Medical Cannabis Strains That Can be Used to Treat PTSD

FloridaMarijuana.net

PTSD patients lack the necessary endocannabinoids to fill the receptor sites properly. Medical marijuana and cannabinoids can be used to treat a patient’s physical and psychological health, alleviating the debilitating symptoms of PTSD. The study has received full approval from the FDA, DEA, and Institutional Review Boards (IRBs).

Strains 190
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Senators Call For Report On State Of Psychedelic Research

Cannabis Law Report

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] 8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. Defining Psychedelics.

article thumbnail

The Ketamine Clinic Craze: Legalities and Possibilities

Canna Law Blog

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. According to the FDA , “once the FDA approves a drug, healthcare providers generally may prescribe the drug for an unapproved use when they judge that it is medically appropriate for their patient.”

Therapy 89
article thumbnail

New Frontiers in the Law of Psychedelics

Cannabis Law Report

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. See Deborah Brauser, FDA Permits Psilocybin to Be Tested for Refractory Depression, MEDSCAPE (Oct.

Law 105
article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Later that year, Doblin sued the DEA for the first time. Lyle Craker, Ph.D.,

article thumbnail

Can Marijuana Help The Opioid Crisis?

The Herb Collective

Unfortunately, CBD is still labeled as high potential for abuse by the DEA. In 2017, President Trump declared the opioid addiction epidemic a public health emergency citing it as the leading cause of lethal drug overdose in the same year. It also is being acknowledged as a treatment for anxiety, joint pain and cancer.